Share this page!

🇺🇸🤝🇺🇦eastvillagetwt Profile picture
Twitter logo
Nov 30 • 4 tweets • 4 min read
‘I’m just carrying on’: vaccine gives brain cancer patient years of extra life

The revolutionary DCVax-L vaccine has allowed Nigel French to live a normal life seven years after a brain cancer diagnosis #DCVaxL $NWBO #CancerVaccine #Glioblastoma #Phase3

theguardian.com/science/2022/n…
Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma $NWBO #DCVaxL #CancerVaccine #GBM

A Phase 3 Prospective Externally Controlled Cohort Trial

jamanetwork.com/journals/jamao…
More long-term Survivors, $NWBO #DCVaxL a personalized general therapeutic #CancerVaccine to treat any kind of solid tumor cancer anywhere in the body.

Other $NWBO investors, I think you'll find this book well worth reading or listening to... It's totally on point, #DCVaxL #CancerVaccine. @DrSidMukherjee

• • •

Missing some Tweet in this thread? You can try to force a refresh
　

Keep Current with 🇺🇸🤝🇺🇦eastvillagetwt

🇺🇸🤝🇺🇦eastvillagetwt Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @eastvillagetwt

🇺🇸🤝🇺🇦eastvillagetwt Profile picture
Nov 30
@matthwilliams @NWBIO @braintumourrsch @BrainTumourOrg Dude, your conflict of interest is all over you and this criticism. Let the regulators do their jobs. You focus on your patients and BUSINESS interests. Let the regulators, patients and market decide what they would prefer. You’re disgracing yourself in the field.
@matthwilliams @NWBIO @braintumourrsch @BrainTumourOrg Let's recall that Optune costs £20,000 per month in the UK, or £240,000 per year, as long as the patient lives, an incredibly expensive treatment, which is why the NHS only covers it for a limited group of patients. It's burdensome, expensive & requires 18 hrs a day compliance.
@matthwilliams @NWBIO @braintumourrsch @BrainTumourOrg Call for NHS to fund £240,000 cancer treatment Optune

bbc.com/news/uk-englan…

I can see why you'd prefer such an expensive treatment, forever, over a treatment that could make potentiatlly he same number of patients free from treatment at all.
Read 9 tweets
🇺🇸🤝🇺🇦eastvillagetwt Profile picture
Nov 11
$NWBO #DCVaxL New name #murcidencel
SNO Abstract, just released, for presentation by #DrLindaLiau on November 20th:

Background: Standard of care (SOC) and patient survival in glioblastoma have changed little in the past 17 years.
We evaluated in a phase 3 trial whether adding an autologous tumor lysate-loaded dendritic cell vaccine (murcidencel) to SOC extends survival. Patients and

Methods: Newly diagnosed glioblastoma patients were randomized 2:1 to either murcidencel or placebo.
Under a crossover design, all patients could receive murcidencel following tumor recurrence. All parties remained blinded regarding treatments before recurrence. Patients thus received murcidencel at new diagnosis (nGBM) or at recurrence (rGBM) following crossover from placebo.
Read 17 tweets
🇺🇸🤝🇺🇦eastvillagetwt Profile picture
Nov 11
#TrumptyDumpty - I knew someday it would become a thing.
Way back a long time ago... #TrumptyDumpty

Back to 2015...
twitter.com/search?q=trump…
2015:

Read 4 tweets
🇺🇸🤝🇺🇦eastvillagetwt Profile picture
Aug 23
Northwest Biotherapeutics Announces -

Approval of Pediatric Investigation Plan (PIP) by MHRA

#DCVaxL $NWBO newsfilter.io/a/8ae27d3f0428…
“The development, regulatory review and regulatory approval of a PIP is a pre-requisite for application for approval of a new medicine for adult patients, such as DCVax®-L.”
“The Company submitted its proposed PIP to the MHRA in February 2022, and has been going through the regulatory review process since then.  On August 17, the Company received final approval of the PIP from the MHRA.”
Read 9 tweets
🇺🇸🤝🇺🇦eastvillagetwt Profile picture
Aug 23
Dr. Keyoumars Ashkan #DrKeyoumarsAshkan Surgeon & professor, and he also ran the European trials for #DCVaxL from $NWBO
Professor Ashkan performs life-saving awake brain tumour surgery while patient plays violin! via @YouTube
$NWBO #DCVaxL #Glioblastoma Phase 3 trial results presented by #DrKeyoumarsAshkan

Read 4 tweets
🇺🇸🤝🇺🇦eastvillagetwt Profile picture
May 13
$NWBO DEDUCED RECKONING: Northwest Bio reports Phase 3 results.

#DCVaxL
@joanlappin

finance.yahoo.com/news/deduced-r…
1/ "Only 5% of glio patients survive for five years. So how stunning is it for DCVAX-L to see life expectancy at 60 months rise from 5.7% to 13%, an increase of 228%. Some patients have seen total remission glio and are cancer free more than a decade after treatment.
2/ For example, Brad Silver participated in the Phase 1 trial 17 years ago and is cancer free now."

Read 81 tweets

Did Thread Reader help you today?

Support us! We are indie developers!

This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us on Twitter!

Send Email!

:(